Literature DB >> 12498998

Effects of vitamin E supplementation on blood antioxidants levels in patients with Behçet's disease.

Ibrahim Kökçam1, Mustafa Naziroglu.   

Abstract

Behçet's disease (BD) is known for many years, yet its etiology remains unknown. In BD, the increased production of reactive oxygen species from activated neutrophils may reduce concentrations of antioxidant vitamins and enzymes in plasma and red blood cells (RBC). Vitamin E is an important fat soluble antioxidant and its role on antioxidant parameters of BD is unclear. The study was undertaken to evaluate the role of vitamin E on lipid peroxidation (MDA) levels, antioxidant vitamin and enzyme concentrations in plasma and RBC in patients with BD. There were three groups i.e., control, patient and treatment groups with twenty-five subjects in each. Nonsmoking patients with BD, patient group, was compared with an equal number of healthy control subjects (control group). Blood samples were taken from both control and patient groups and then oral vitamin E was daily supplemented to the patients with BD for six weeks (treated group). At the end of six weeks, blood was taken from the treated group once more. RBC and plasma MDA levels, serum neopterin, complement system (C(3) and C(4)), ASO, CRP, rheumatoid factor, plasma lipoprotein (a), total cholesterol concentrations and erythrocyte sedimentation rate were higher in the patient group than in the control group, but they were lower in the treatment group than in the patient group. While vitamins A, E and beta-carotene concentrations in plasma, catalase, glutathione peroxidase activities and reduced glutathione levels in RBC and plasma were lower in patient group than in the controls, they were found to be higher in the treatment group than in the patient group. These results provide some evidence for a potential role of increased lipid peroxidation and decreased enzymatic and non enzymatic antioxidants in BD by its inflammatory character and vitamin E which may strengthen the antioxidant defense system, and may contribute to the treatment of BD. Copyright 2002 The Canadian Society of Clinical Chemists

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12498998     DOI: 10.1016/s0009-9120(02)00400-9

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  13 in total

1.  DNA damage and its relationship with other oxidative stress parameters in Behcet's disease.

Authors:  E D Sezer; K Aksu; O Caglayan; G Keser; G Karabulut; G Ercan
Journal:  Rheumatol Int       Date:  2010-09-14       Impact factor: 2.631

2.  Hypericum perforatum modulates apoptosis and calcium mobilization through voltage-gated and TRPM2 calcium channels in neutrophil of patients with Behcet's disease.

Authors:  Mustafa Nazıroğlu; Mehmet Sahin; Bilal Ciğ; Mehmet Aykur; Ijlal Erturan; Yunus Ugan
Journal:  J Membr Biol       Date:  2014-01-23       Impact factor: 1.843

3.  Colchicine modulates oxidative stress in serum and neutrophil of patients with Behçet disease through regulation of Ca²⁺ release and antioxidant system.

Authors:  Selma Korkmaz; Ijlal Erturan; Mustafa Nazıroğlu; Abdulhadi Cihangir Uğuz; Bilal Ciğ; Ishak Suat Övey
Journal:  J Membr Biol       Date:  2011-11-04       Impact factor: 1.843

4.  Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.

Authors:  Ibrahim Eren; Mustafa Naziroğlu; Arif Demirdaş; Omer Celik; A Cihangir Uğuz; Ayşe Altunbaşak; Ismail Ozmen; Efkan Uz
Journal:  Neurochem Res       Date:  2007-03       Impact factor: 3.996

5.  The association between total antioxidant status and oxidative stress in Behçet's disease.

Authors:  Aylin Sepici-Dinçel; Yeşim Ozkan; Sevgi Yardim-Akaydin; Gülçin Kaymak-Karataş; Meltem Onder; Bolkan Simşek
Journal:  Rheumatol Int       Date:  2006-05-20       Impact factor: 2.631

6.  Antistreptolysin O Levels in Patients with Behcet's Disease.

Authors:  Hulya Uzkeser; Saliha Karatay; Kadir Yildirim; Ali Karakuzu; Muhammed Hamidullah Uyanik
Journal:  Eurasian J Med       Date:  2011-12

7.  Thiol/disulfide homeostasis in patients with ocular-active and ocular-inactive Behçet disease.

Authors:  Mehmet Balbaba; Fatih Ulaş; Hakan Yıldırım; Adem Soydan; Ali Dal; Süleyman Aydın
Journal:  Int Ophthalmol       Date:  2020-06-01       Impact factor: 2.031

8.  Serum prolidase enzyme activity and oxidative status in patients with Behçet's disease.

Authors:  Mehtap Bozkurt; Hatice Yüksel; Serda Em; Pelin Oktayoglu; Mehmet Yildiz; Dicle Akdeniz; Kemal Nas
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

9.  Is 4-Hydroxynonenal a Predictive Parameter for the Development of Joint Erosion in Patients With Rheumatoid Arthritis?

Authors:  Gürkan Akgöl; Hasan Ulusoy; Selda Telo; Arif Gülkesen; Tülay Yildirim; Ahmet Kürşad Poyraz; Arzu Kaya
Journal:  Arch Rheumatol       Date:  2016-03-22       Impact factor: 1.472

10.  Beta-Carotene, Vitamin E, MDA, Glutathione Reductase and Arylesterase Activity Levels in Patients with Active Rheumatoid Arthritis.

Authors:  N Aryaeian; M Djalali; F Shahram; Sh Jazayeri; M Chamari; Sa Nazari
Journal:  Iran J Public Health       Date:  2011-06-30       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.